Free Consultation

(858) 220-1166

Category: Cannabis

FDA Issues Warning Letters for Ingestible Hemp-Derived CBD

December 9, 2019 | Cannabis,Intellectual Property

On November 25, 2019, the U.S. Food and Drug Administration (“FDA”) sent warning letters to fifteen (15) companies for selling products containing cannabidiol (“CBD”) in violation of the Food, Drug, and Cosmetic Act (“FDCA”). The basis for the warning letters was that the FDA lacks scientific information supporting the safety of CBD in food/ingestibles –…

Read More